HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer

Type II endometrial cancers (uterine serous papillary and clear cell histologies) represent rare but highly aggressive variants of endometrial cancer (EC). HER2 and EGFR may be differentially expressed in type II EC. Here, we evaluate the clinical role of HER2 and EGFR in a large cohort of surgicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Konecny, G E, Santos, L, Winterhoff, B, Hatmal, M, Keeney, G L, Mariani, A, Jones, M, Neuper, C, Thomas, B, Muderspach, L, Riehle, D, Wang, H-J, Dowdy, S, Podratz, K C, Press, M F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634683/
https://www.ncbi.nlm.nih.gov/pubmed/19088718
http://dx.doi.org/10.1038/sj.bjc.6604814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634683/
https://www.ncbi.nlm.nih.gov/pubmed/19088718
http://dx.doi.org/10.1038/sj.bjc.6604814

Ejemplares similares